Erratum by unknown
Exposure to a Fungal Volatile
Compound: Significance of
Effects
In contrast to what Wålinder et al. (2005)
concluded in their article “Acute Effects of
a Fungal Volatile Compound,” I interpret
the article to report essentially no effects
beyond chance. In all, the authors carried
out some 76 comparisons (each one repre-
senting a time point and an exposure vs.
control measurement) if you take blink fre-
quency as a single comparison. The authors
reported finding 5 “significant differences”
out of 76 comparisons. Of the reported sig-
nificant differences, one (blink frequency) is
misleading, as discussed below. Of the
remaining 75 comparisons, 4 differences at
a p-value of < 0.05 might be expected by
random chance. This is without applying
Bonferroni’s adjustment for multiple com-
parisons; using this adjustment, a p-value of
approximately < 0.0007 would be required
for a single comparison to be statistically
significant. None of the differences reported
reached this level. 
Wålinder et al. (2005) reported that the
subjects showed increased “blink frequency”
during 3-methylfuran (3-MF) exposure
(Table 1), but the frequency was higher in
the exposure phase at time 0, about 9 for
3-MF exposure versus 6.5 for the control
air phase. From the data in Table 1, it
appears that both groups had fewer overall
blinks per minute compared with baseline
during the trial (Figure 2). Reporting that
blinking was higher during exposure and
not noting that it was higher at baseline is
disingenuous. 
Wålinder et al. (2005) may have mis-
labeled tear break-up, but as it reads in the
legend for Table 1, a negative value indicates
a decrease; therefore, the 6 sec given for mea-
sured break-up time after 3-MF exposure
(Table 1) indicates that it was increased (i.e.,
longer to tear break-up), which is better. Is
this correct? Also, was the observer who
measured the tear break-up blinded to the
exposure? 
Finally, of the four lung measurements
taken, the only comparison with a p-value of
< 0.05 was the small 100-mL change for
forced vital capacity (FVC) right after expo-
sure (Table 4). How do the authors inter-
pret this change in FVC in view of the fact
that there was no significant change in
forced expiratory volume in 1 sec (FEV1)? 
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mold litigation.
Andrew Saxon
Department of Medicine
UCLA Medical School
Los Angeles, California
E-mail: asaxon@mednet.ucla.edu
REFERENCE
Wålinder R, Ernstgård L, Johanson G, Norbäck D, Venge P,
Wieslander G. 2005. Acute effects of a fungal volatile
compound. Environ Health Perspect 113:1775–1778.
Exposure to a Fungal Volatile
Compound: Wålinder et al.
Respond
There are different opinions on the use of
Bonferroni’s corrections. Everitt (1995)
stated that it gives too conservative esti-
mates if there are more than five tests per-
formed. In environmental medicine, one
exposure can have different health effects,
so it is reasonable to test for different types
of effects on different organs. We prefer to
perform conventional statistical tests, with-
out Bonferroni correction, and look at the
pattern of significant effects and their bio-
logic plausibility. 
We did not perform 76 comparisons
(Wålinder et al. 2005); we actually per-
formed 25 tests on 13 physiologic variables
based on differences before and after expo-
sure. A fourteenth variable (vital staining)
was tested only after exposure. Repeated
measurement analysis was performed on
blink frequency (60 consecutive measure-
ments of 2 min each) and one questionnaire
with 10 questions was administered at six
different times. This is a total of 37 tests per-
formed on 25 variables, having five signifi-
cant values, of which one was highly
significant (p < 0.001).
Moreover, all tests point in the same
direction—mucosal effects of the exposure.
We did not find the same effects over time
for control exposure. There is, of course,
the possibility that some of the significant
effects were due to chance, and we were
quite modest in our conclusions, using the
words “may” or “might be.” Because our
study is the first exposure-chamber study on
3-methylfuran (3-MF), more studies are
needed to determine final conclusions. 
Blink frequency was measured only dur-
ing the 2 hr of exposure in the chamber.
Therefore, there is no preexposure baseline
data available at time 0. Eye effects occur
quickly; a rapid effect of the exposure on
blinking frequency can occur during the
first 2 min of exposure to 3-MF inside the
chamber, possibly followed by later adapta-
tion (8.8 blinks/min during the first 2 min,
compared with a mean of 7.6 blinks/min
during the whole period of exposure).
It is true that there was a numerical
increase in break-up time at exposure, which
could be in agreement with increased blink
frequency. The fatty layer on the tear film is
produced by the glands of the eyelids.
Therefore, an increased blinking frequency
could produce more secretion from the
meibomian glands and therefore a longer
break-up time.
Regarding lung function, transient effects
of environmental exposure (as well as diurnal
variation, which we controlled for by per-
forming the experiment at the same time)
may affect either forced vital capacity (FVC)
or forced expiratory volume in 1 sec (FEV1),
or both. Physiologically and numerically,
the decrease was of the same order, but sta-
tistically the outcome was different. The
decreases were 0.1 L for FVC and 0.08 L for
FEV1 after exposure to 3-MF. The magni-
tude of the effect was clinically small, but it
was significant at group level for FVC. Small
pulmonary effects may have large health
effects in a population (Künzli et al. 2000.)
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Organophosphates and
Outdoor Air Concentrations
Harnly et al. (2005) suggested that measured
air concentrations of organophosphate insec-
ticides may pose a particular concern for
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ing the current scientific weight of evidence,
their conclusions cannot be supported for
two reasons: first, they did not demonstrate a
particular concern for children based on their
results, and second, they cited incomplete
and inappropriate literature to support the
notion that recent toxicologic and epidemio-
logic studies indicate a health concern.
Harnly et al. (2005) did not conduct a
risk assessment to demonstrate a concern
for children. Rather, they detected pesti-
cides in air concentrations in agricultural
areas and then suggested there may be a
concern for children because of recent toxi-
cologic and epidemiologic studies. Their
observed median exposures of all three
active ingredients (chlorpyrifos, diazinon,
and malathion) were all low and well within
established regulatory limits. A risk assess-
ment approach would have been quite use-
ful. For chlorpyrifos, Harnly et al. (2005)
detected a 20-day median concentration in
air of 0.000033 mg/m3. A tier-1 risk assess-
ment assuming an air concentration of
chlorpyrifos at 0.000033 mg/m3, the mean
body weight of a 1- to 2-year-old child of
12.3 kg, a child inhalation rate of 
6.8 m3/day, and 24-hr outdoor respiration
results in a chlorpyrifos inhalation exposure
of 0.0000182 mg/kg/day. Margins of expo-
sure (MOE) would be 5,495 [acute inhala-
tion no observed adverse effect level
(NOAEL) = 0.1 mg/kg/day], 27,473 (acute
NOAEL = 0.5 mg/kg/day), and 1,648
(chronic NOAEL = 0.03 mg/kg/day).
All MOEs are greater than the U.S. Environ-
mental Protection Agency (EPA) target
MOE of 1,000 for infants, children, and
females 13–50 years of age (U.S. EPA 2002).
More problematic is that Harnly et al.
(2005) stated that 
Recent cellular, animal, and human evidence of
toxicity, particularly in newborns, supports the
public health concern indicated by initial risk
estimates.
The authors did not provide a sufficiently
thorough review of the literature relevant to
risk assessment to support or refute their
statement. In the case of chlorpyrifos, this
statement cannot be supported by the avail-
able evidence. The principal problem with
Harnly et al.’s approach is not unique to their
article. Appropriate risk assessment requires
appropriate data, and, as simple as this rela-
tionship sounds, it is often ignored. Harnly
et al. (2005) cited toxicity and epidemiologic
studies, but these particular studies are not
appropriate for use in risk assessment. This
problem has become so pervasive that
Conolly et al. (1999) clarified the basic fea-
tures of toxicology studies that are and are
not appropriate for use in risk assessment. 
Harnly et al. (2005) should not have
included the findings of Qiao et al. (2002)
because the high doses, subcutaneous route
of administration, and carrier were inappro-
priate for toxicologic risk assessment
(Conolly et al. 1999; Zhao et al. 2005).
Indeed, Slotkin (2004), a coauthor of Qiao,
has written that there is little academic inter-
est in relevant routes of exposure or
pharmacokinetics. He stated that 
Practical issues that are critical to standardized test-
ing are de-emphasized, such as pharmacokinetics/
toxicokinetics, the matching of routes of exposure
to those of humans in industrial, agricultural or
domestic settings, or the development of biologi-
cally-based dose response models of established
hazards. In that sense, the academic approach is
entirely deficient in those attributes that are neces-
sary components of the application of research
findings to regulatory science.
Harnly et al. (2005) cited Eskenazi et al.
(1999) as a source of concern for adverse
consequences of organophosphate exposure.
To be complete, Eskenazi et al. (2004) pro-
vide more information. They stated, “We
failed to demonstrate an adverse relationship
between fetal growth and any measure of
in utero organophosphate pesticide expo-
sure.” An association was found for a couple
of variables and decreased gestational dura-
tion, but the conclusion was that these
potential pesticide effects appear to have “lit-
tle clinical impact at the population level.”
Finally, air concentrations have been
shown to translate poorly into systemic expo-
sure. Hore et al. (2005) showed that children
in houses treated with chlorpyrifos had no
detectable increase in urinary 3,5,6-trichloro-
pyridinol (TCP), whereas median peak
ambient air chlorpyrifos increased > 10-fold
(median of 14 ng/m3 pretreatment, 196
ng/m3 on day of treatment). If a 10-fold
increase in air chlorpyrifos does not cause a
detectable increase in urinary TCP, then the
1-fold background air cannot be contribut-
ing measurably to the children’s background
levels of urinary TCP.
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Organophosphates and
Outdoor Air: Harnly et al.
Respond
Peterson is incorrect in stating that we did
not conduct a risk assessment. We summa-
rized in our article (Harnly et al. 2005) and
detailed in a previous article (Lee et al.
2002) a human health risk assessment
demonstrating elevated acute and sub-
chronic risks for children’s exposures to
ambient chlorpyrifos air concentrations in
agricultural communities. Compared with
the assessment by Peterson, we used a more
refined probability distribution analysis,
included air levels of the degradation product
(chlorpyrifos oxon), and presented exposures
relative to reference values. The chlorpyrifos
reference values, however, were based on the
same no-observed-adverse-effect levels
(NOAELs) and the same 10-fold intraspecies
and interspecies, and child uncertainty fac-
tors used in Peterson’s calculations. 
In our article (Harnly et al. 2005), we
suggested that our risk assessment may
underestimate risks for several reasons, such
as a) risk assessments that use NOAELs,
and not the entire dose–response curve,
tend to underestimate risks (Castorina and
Woodruff, 2003); and b) the true ranges of
intraspecies and interspecies variability are
unknown and may be larger than the fac-
tors used (Eskenazi et al. 1999; Faustmann
et al. 2000). In a very recent study, some
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metabolize diazoxon and chlorpyrifos oxon
than their mothers (Furlong et al. 2006). To
further support the concern for children
indicated by our quantitative risk assess-
ment, we cited toxicologic studies establish-
ing that in addition to chloinesterase
inhibition, on which the NOAEL for chlor-
pyrifos is established, chlorpyrifos and chlor-
pyrifos oxon have other neurodevelopmental
toxicity mechanisms (Huff et al. 1994; Qiao
et al. 2002). We also noted that cell death
has been induced at the reference dose for
drinking water (Greenlee et al. 2005).
Peterson argues that the toxicologic stud-
ies we cited (Castorina and Woodruff, 2003;
Eskenazi et al. 1999; Faustmann et al. 2000;
Greenlee et al. 2005; Huff et al. 1994; Qiao
et al. 2002) are an insufficient review of the
“literature relevant to risk assessment” and
that these studies are not appropriate for use
in risk assessment. However, in missing the
fact that we conducted a quantitative risk
assessment, Peterson is misinterpreting our
citations as the only basis for our public
health concern. We consider it our public
health responsibility to at least qualitatively
consider recent toxicologic data in addition
to a quantitative risk assessment based on
established reference values. Others have
argued for a complete restructuring of risk
assessment for children, including toxico-
kinetic modeling and assessment of cellular
and molecular outcomes over the entire life-
span of experimental subjects (Landrigan
et al. 2004). 
For many reasons we disagree with the
suggestion that the epidemiologic fetal
growth and gestational duration findings of
Eskenazi et al. (2004) may be used to dis-
regard concern for in utero and child
organophosphate exposure highlighted by
Eskenazi et al. (1999). The associations of
reduced gestational duration with dimethyl
organophosphate urinary metabolites and
chloinesterase inhibition were not clinically
significant in the California population
studied (recent Mexican immigrants who
tend to have very healthy birth outcomes).
However, a shortened gestational age of a
half-week would represent, for some
women, a risk of preterm delivery (Eskenazi
et al. 2004). Clearly, this finding and the
absence of any adverse association between
fetal growth and measures of in utero pesti-
cide exposure need to be confirmed or
refuted. To be complete, however, we also
cited the association found in a New York
City population between low birth weight
and length and cord plasma levels of chlor-
pyrifos and diazinon (n = 314) (Whyatt
et al. 2004). Further, effects of organophos-
phate pesticide exposure on early child
neurodevelopment have been found (Young
et al. 2005) and are continuing to be evalu-
ated in the California and the New York
City cohorts. Finally, public health policy is
typically developed to protect against a 1 in
1,000, or lower, risk, and the epidemiologic
studies cited here are below the sample size
necessary to detect such risks. 
Peterson notes that a study of children in
10 homes did not demonstrate an association
with child urine metabolite levels of chlor-
pyrifos and ambient air levels following crack
and crevice treatment (Hore et al. 2005).
Yet, the authors of that study were careful to
note a number of study limitations, includ-
ing the variability and accuracy of the child
urinary metabolite readings. We also note
that chloryprifos oxon, which also breaks
down into the measured urinary metabolite,
was not measured in air; air concentrations
in four of the study homes were not elevated
compared to pretreatment levels; and per-
sonal air samples were not collected (Hore
et al. 2005). Among mothers in New York
City (n = 314) in another study, 48-hr per-
sonal air samples collected during pregnancy
were associated with cord and maternal
blood levels of chlorpyrifos (Whyatt et al.
2004). This is the same study population
within which an association with adverse
birth outcomes and pesticide cord blood lev-
els has been demonstrated, and the chlor-
pyrifos air levels are in the same (average,
15 ng/m3) range, if not lower, as those evalu-
ated in our health risk assessment (Whyatt
et al. 2004). 
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Effects of BPA in Snails
It is an ethical requirement that new find-
ings be presented in light of and in conjunc-
tion with a balanced evaluation of the
current knowledge and published literature.
lated this general principle in several ways.
For example, the authors inferred that
prosobranch snails have a functional estro-
gen receptor and therefore a much higher
sensitivity to estrogens and endocrine-dis-
rupting compounds (EDCs) than other
species previously reported in the literature.
We found several other problems in their
article: 
reveal the source of the animals used in
their study, thus prohibiting independent
repetition of the experiments by others.
Second, the authors stated that male
and female Marisa cornuarietis cannot be
distinguished morphologically without
killing the animals. Therefore, the lack of
data on the sex distribution of the animals
sampled at each time-point leads us to ques-
tion the stability of the experimental condi-
tions with regard to sex ratios and thus
reproductive conditions. Furthermore, the
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We believe that Oehlmann et al. (2006) vio-
First, Oehlmann et al. (2006) did notrapidly changing snail density, and hence
the sex distribution at each sampling time
point, certainly influenced the remaining ani-
mals with respect to mortality and fecundity. 
Third, the experimental design and the
lack of replication (Experiment 1) did not
allow for sound statistical analysis; the sta-
tistical methods used were inappropriate,
making correct interpretation impossible.
Of most concern to us was the analysis of
data by analysis of covariance (ANCOVA),
mainly because the ANCOVA-inherent
assumption of independency of the depen-
dent variable (i.e., total number of eggs) is
violated. Thus, small differences among
aquaria (treatment groups) might have been
propagated over time, resulting in the
impression of large differences.
Fourth, we believe that carrying out
receptor binding experiments only in
duplicate and without Scatchard analysis is
questionable per se. The number of concen-
trations tested was extremely limited and
consequently cannot allow accurate descrip-
tion of binding curves. Oehlmann et al.
the assessment of unspecific binding and the
reported IC50 values (concentration causing
50% inhibition) are approximately three
orders of magnitude higher than what would
be expected if this were a real sex-steroid
receptor interaction. Because tamoxifen did
not elicit a typical and highly specific recep-
Figure 3), we question the use of tamoxifen
as an “antiestrogen” in this in vivo study.
Finally, the data in Figure 1B (Oehlmann
Schulte-Oehlmann et al. (2001), yet the
originally published data did not incorpo-
rate 17α-ethinylestradiol (EE2) as positive
control. Moreover, the EE2 curve in
Figure 1B appears identical to the one on
slide 14 from a slide presentation available
on Oehlmanns’ website (Schulte-Oehlmann
et al. 2006).
The use of a positive control is com-
mendable when the mode of action is
known [National Toxicology Program
(NTP) 2001]; however, as in the study of
knowledge precludes the inclusion of a pos-
itive control as proof-of-principle. Slide 14
(Schulte-Oehlmann et al. 2006) demon-
strates that EE2 does not have a monotonic
mode of activity in M. cornuarietis, but
rather appears to stimulate egg laying at
10–25 ng EE2/L, inhibit egg laying at 50 ng
EE2/L and has no effect at 1 and 100 ng
EE2/L. On the basis of in vitro and in vivo
we question the presence of any estrogen
receptor–like interaction. In view of the
NTP (2001) definitions and use of con-
trols, the use of EE2 as a “positive” control,
with its nonmonotonic and nonhormetic
dose–response curve in comparison with
BPA (which has a presumably monotonic
response curve), as well as the use of an
antiestrogen (tamoxifen), is inappropriate.
In conclusion, the data presented by
Flaws in the experimental design, data pre-
sentation, and interpretation as well as sta-
tistical analyses render their findings
untenable. Furthermore, the “Introduction”
and “Discussion” of their article was written
in a way that could be considered highly
imbalanced and indeed alarmist. The highly
selective inclusion/omission and discussion
of previously published research that con-
tradicts the authors’ opinion (e.g., Pickford
et al. 2003) is particularly disturbing. It is
our opinion that our evaluation of the
Oehlmann et al. work serves as a useful
reminder to scientists that we must con-
stantly strive to formulate clear hypotheses,
use sound experimental designs, employ
appropriate statistics, and draw conclusions
that are supported by the available data and
that reflect a balanced assessment of the 
scientific literature to avoid jumping to
erroneous conclusions.
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Effects of BPA in Snails:
Oehlmann et al. Respond
We welcome critical appraisals that help to
provide balance; however, Dietrich et al.
gave an unjustified reproach. We feel that
Dietrich’s position is severely compromised
because he serves as an expert for the bisphe-
nol A (BPA) Industry Group (Brussels,
Belgium). We would like to respond to the
issues raised by Dietrich et al., as well as to
their oversights and inappropriate interpreta-
tions of our findings.
The source of test animals was clearly
provided in our “Materials and Methods”
was known for each time-point of the exper-
iment. We supposed a 1:1 sex ratio for dead
snails, although historical data (n > 14,000)
indicate a slight prevalence of females
(1.13:1); therefore, our assumption was con-
servative. Egg production was corrected for
the number of females in the tanks, and
snail densities were equal for all groups at
each time-point.
Semistatic designs are widely applied in
scientific and regulatory ecotoxicology
[Organization for Economic Development
and Co-operation (OECD) 1998]. The
actual exposure concentrations of BPA were
measured and clearly communicated in our
Because 17α-ethinylestradiol (EE2) is more
stable than BPA (Larsson et al. 1999), expo-
sure to the positive control is also guaran-
teed in our 24-hr renewal test. Interestingly,
Dietrich himself coauthored a semistatic
study on snails (Czech et al. 2001) with sev-
eral shortcomings: they used no analytical
verification of exposure concentrations, no
replicates, and inconsistent group size.
Analysis of covariance (ANCOVA) analy-
ses of fecundity, development, and other
cumulative data are widely used (Bochdansky
and Bollens 2004; Dziminski and Alford
2005; Schärer and Wedekind 1999). In our
experiment 2 with replicates (Oehlmann
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(2006) provided no information regarding
Oehlmann et al. (2006), the lack of such
effects reported by Oehlmann et al. (2006),
Oehlmann et. al. (2006) are unconvincing.
dissected and sexed; thus, sex distribution
et al. 2006) were published earlier by
(Oehlmann et al. 2006). All animals were
Tables 1 and 2 (Oehlmann et al. 2006).
et al. 2006), ANOVA confirmed the
tor binding curve (Oehlmann et al. 2006,ANCOVA results (Figure 2A,2C). A BPA
Industry Group–sponsored statistical
reevaluation of our raw data (Ecostat 2005)
concluded that “at 20°C the mean egg pro-
duction increased compared to the control
in the BPA-exposed females at all applied
concentrations (0.25, 0.5, 1 and 5 µg/L),
and decreased in the BPA+faslodex- or
tamoxifen-exposed females.”
We achieved an association for a steady
state of specific binding in three indepen-
dent time-course studies (Oehlmann et al.
ands resulting in clear specific binding for
testosterone and estradiol. At higher concen-
trations, nonspecific binding was 70%,
comparable with findings of Chou and
Dietrich (1999), who also performed their
experiments in duplicate. This percentage
might be due to homogenization of large
amounts of tissue with high protein content
but a limited degree of specific cytosolic
binding sites. In our study (Oehlmann et al.
plete binding study in which saturation
experiments with Scatchard analysis are
needed, but to provide indications for the
presence of estrogen receptors by a specific
binding of ligands to cytosolic extracts (a
widely used practice). Tamoxifen was not
disqualified as an antiestrogen because it
elicited a binding higher than that of BPA.
Furthermore, in vitro ligand affinities have a
limited predictive value for biologic poten-
cies in vivo (Kloas et al. 1999). In summary,
the binding study was performed appropri-
ately for the desired purpose and provides
initial evidence for specific estrogen binding
sites with high affinity for BPA.
Data presented in our Figure 1B
Schulte-Oehlmann et al. (2001) without EE2
because the focus of that work was compar-
ing responses to BPA in four prosobranch
species, including Marisa. Because the article
was published in German, the distribution
was not large enough to bring the issue to a
wider audience. In the current article
2 data were
included to demonstrate the masking of
BPA effects during the spawning season.
Because future BPA industry-sponsored
studies intend to investigate BPA effects
under conditions maximizing reproduction,
the problem of masked effects and an associ-
ated loss of sensitivity is of vital importance.
Responses in Marisa (ruptured oviducts,
increased spawning) are estrogen specific and
opposite of androgenic effects (imposex,
reduced spawning). This and evidence com-
municated in our article (Oehlmann et al.
2 to demonstrate
the responsiveness of organisms. Non-
monotonic concentration responses have also
been reported for estrogen-regulated end
points in EE2-exposed fish (Pawlowski et al.
2004), supporting our view that estrogen-
specific binding sites in Marisa may repre-
sent functional receptors.
Dietrich et al.’s charges that our
“Introduction” and “Discussion” were
“imbalanced and indeed alarmist” and that
we selectively used literature are unjustified.
We hope that the evidence presented
here serves to refute the unjustified claims
made by Dietrich et al. We leave it to the
readers to make final judgment, but we feel
that with the ever-increasing body of evi-
dence showing effects of BPA on reproduc-
tion in various animal species, common
sense will eventually prevail on this issue.
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ERRATUM
In the article by Colbert et al. [Environ Health Perspect 113:700–707 (2005)], the
authors discovered an error in the units of exposure estimates in the tenth paragraph of
the “Discussion.” These estimates are expressed in milligrams but should be expressed
in micrograms. The corrected sentences are as follows: 
It is estimated that children 1–6 years of age are exposed to 0.167 µg Vz/kg body weight/day ….
Given this chronic exposure estimate, a 2-year-old boy who weighs 13 kg … would consume an aver-
age of 2.17 µg Vz/day, whereas a 6-year-old with a body weight of 21 kg would consume an average of
3.51 µg Vz/day. 
using a 1,000-fold excess of unlabeled lig-
2006). We determined nonspecific binding
2006), we did not intend to deliver a com-
(Oehlmann et al. 2006) were published in
(Oehlmann et al. 2006), EE
2006) justify the use of EE